Traws Pharma, Inc. Interest Expense
Traws Pharma, Inc. (TRAW) reported Interest Expense of $2.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-30.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-03-30
- Traws Pharma, Inc. interest expense for the quarter ending 2013-12-31 was $1.00K.
- Traws Pharma, Inc. interest expense for the quarter ending 2013-09-30 was $1.00K, a 99.99% decline year-over-year.
- Traws Pharma, Inc. interest expense for the quarter ending 2013-06-30 was $2.00K, a 99.13% decline year-over-year.
- Traws Pharma, Inc. interest expense for the quarter ending 2012-12-31 was $0.00.
- Traws Pharma, Inc. interest expense for fiscal 2014 was $2.00K, a 50.00% decline from fiscal 2013.
- Traws Pharma, Inc. interest expense for fiscal 2013 was $4.00K, a 99.95% decline from fiscal 2012.
- Traws Pharma, Inc. interest expense for fiscal 2012 was $8.61M, a 45205.26% increase from fiscal 2011.
- Traws Pharma, Inc. interest expense for fiscal 2011 was $19.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2014-12-31 | $2.00K 10-K · filed 2015-03-30 | |||
| 2013-12-31 | $1.00K 10-K · filed 2015-03-30 | $2.00K derived: sum of 2 quarters · filed 2015-03-30 | $4.00K derived: sum of 3 quarters · filed 2015-03-30 | $4.00K 10-K · filed 2015-03-30 |
| 2013-09-30 | $1.00K 10-K · filed 2015-03-30 | $3.00K derived: sum of 2 quarters · filed 2015-03-30 | $3.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.00K 10-K · filed 2015-03-30 | $2.00K 10-Q · filed 2013-09-06 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $8.36M derived: sum of 2 quarters · filed 2015-03-30 | $8.59M derived: sum of 3 quarters · filed 2015-03-30 | $8.61M 10-K · filed 2015-03-30 |
| 2012-09-30 | $8.36M 10-K · filed 2014-03-20 | $8.59M derived: sum of 2 quarters · filed 2014-03-20 | $8.61M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $230.00K 10-K · filed 2014-03-20 | $251.00K 10-Q · filed 2013-09-06 | ||
| 2012-03-31 | $21.00K 10-K · filed 2014-03-20 | |||
| 2011-12-31 | $19.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |